Skip to main content
Year archive

Kingworld Medicines Group Limited — 2023 filings

All 29 regulatory filings released by Kingworld Medicines Group Limited (1110) in 2023, sourced directly from the official regulator.

29 Filings
2023 Period
2023 filings (29)
Filing Released Lang
CONTINUING CONNECTED TRANSACTIONS - PROPOSED ANNUAL CAPS FOR THE THREE YEARS ENDING 31 DECEMBER 2026
Regulatory Filings
2023-12-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Share Issue/Capital Change
2023-10-06 English
Interim Report 2023
Interim / Quarterly Report H1 2023
2023-09-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report H1 2023
2023-08-28 English
DISCLOSEABLE TRANSACTION - FURTHER SUBSCRIPTION OF SHARES IN TAIKO PHARMACEUTICAL CO., LTD.
Capital/Financing Update
2023-08-16 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-08-15 English
POSITIVE PROFIT ALERT
Earnings Release H1 2023
2023-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-02 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2023
Declaration of Voting Results & Voting Rights Announcements
2023-05-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-03 English
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF SHARES IN TAIKO PHARMACEUTICAL CO., LTD.
Capital/Financing Update
2023-04-24 English
Form of proxy for use by shareholders at the annual general meeting to be held on 29 May 2023 at 10:00 a.m.
AGM Information
2023-04-21 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-21 English
(1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED RE-APPOINTMENT OF AUDITOR, (3) PROPOSED DECLARATION OF FINAL DIVIDEND, (4) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND REPURCHASE SH
AGM Information
2023-04-21 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
Environmental & Social Information
2023-04-21 English
ANNUAL REPORT 2022
Annual Report FY 2022
2023-04-21 English
(1) GRANT OF AWARD PURSUANT TO THE SHARE AWARD SCHEME AND (2) EXEMPTED CONNECTED TRANSACTION - GRANT OF AWARD TO CONNECTED PERSONS
Capital/Financing Update
2023-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
Final Dividend for the year ended 31 December 2022 and Closure of Register of Members
Notice of Dividend Amount
2023-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report FY 2022
2023-03-30 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-03-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English